Greenwich LifeSciences (GLSI) said Thursday that its board of directors has extended the lock-up period for shares owned by its directors, officers, and existing pre-IPO investors.
The biopharmaceutical company said it has extended the lockup until March 31, 2026, or roughly five and a half years after the company's IPO.
Officers, directors, and certain shareholders will be unable to sell their shares during the lock-up period, unless the board modifies it, the company said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。